Phase I/II trial of soluble-beta-1,3/1,6-glucan in children with metastatic high-risk (stage IV) neuroblastoma
Phase of Trial: Phase I/II
Latest Information Update: 14 Jul 2011
At a glance
- Drugs Monoclonal antibody 3F8; Soluble beta 1,3-1,6 glucan
- Indications Neuroblastoma
- Focus Therapeutic Use
- Sponsors Biotec Pharmacon
- 14 Jul 2011 Status changed from active, no longer recruiting to completed, according to information in a Biotec Pharmacon media release.
- 22 Jan 2009 New trial record.
- 13 Jan 2009 Enrollment is now complete, according to a Biotec Pharmacon media release.